RECURRENT WORLD HEALTH ORGANIZATION (WHO) GRADE II GLIOMA

Clinical trials for RECURRENT WORLD HEALTH ORGANIZATION (WHO) GRADE II GLIOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT WORLD HEALTH ORGANIZATION (WHO) GRADE II GLIOMA trials appear

Sign up with your email to follow new studies for RECURRENT WORLD HEALTH ORGANIZATION (WHO) GRADE II GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

New drug duo tested in fight against recurrent childhood brain tumors

Disease control Recruiting now

This early-stage trial is testing the safety and best doses of two oral drugs, trametinib and everolimus, given together to children and young adults whose brain tumors have come back after prior treatment. The study aims to see if blocking two different tumor growth pathways at …

Matched conditions: RECURRENT WORLD HEALTH ORGANIZATION (WHO) GRADE II GLIOMA

Phase: PHASE1 • Sponsor: University of California, San Francisco • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

RECURRENT WORLD HEALTH ORGANIZATION (WHO) GRADE II GLIOMA

Get alerted when new RECURRENT WORLD HEALTH ORGANIZATION (WHO) GRADE II GLIOMA trials appear

New drug duo tested in fight against recurrent childhood brain tumors